A citation-based method for searching scientific literature

Lisa Linck-Paulus, Claus Hellerbrand, Anja K Bosserhoff, Peter Dietrich. Cells 2020
Times Cited: 9







List of co-cited articles
46 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets.
Damian Szklarczyk, Annika L Gable, David Lyon, Alexander Junge, Stefan Wyder, Jaime Huerta-Cepas, Milan Simonovic, Nadezhda T Doncheva, John H Morris, Peer Bork,[...]. Nucleic Acids Res 2019
33

Predicting effective microRNA target sites in mammalian mRNAs.
Vikram Agarwal, George W Bell, Jin-Wu Nam, David P Bartel. Elife 2015
33


miRNA-29b Inhibits Prostate Tumor Growth and Induces Apoptosis by Increasing Bim Expression.
Subhayan Sur, Robert Steele, Xingyi Shi, Ratna B Ray. Cells 2019
22
22

miR-129-5p inhibits proliferation, migration, and invasion in rectal adenocarcinoma cells through targeting E2F7.
Ping Wan, Xuan Bai, Chao Yang, Tian He, Lilin Luo, Yun Wang, Minmin Fan, Zhilin Wang, Liming Lu, Yajing Yin,[...]. J Cell Physiol 2020
13
22

Biogenesis of small RNAs in animals.
V Narry Kim, Jinju Han, Mikiko C Siomi. Nat Rev Mol Cell Biol 2009
22


In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancer.
Ramona Rudalska, Daniel Dauch, Thomas Longerich, Katherine McJunkin, Torsten Wuestefeld, Tae-Won Kang, Anja Hohmeyer, Marina Pesic, Josef Leibold, Anne von Thun,[...]. Nat Med 2014
171
22

MiR-622 suppresses proliferation, invasion and migration by directly targeting activating transcription factor 2 in glioma cells.
Rui Zhang, Hui Luo, Shuai Wang, Zhengxin Chen, Lingyang Hua, Hong-Wei Wang, Wanghao Chen, Yongsheng Yuan, Xiaobin Zhou, Daqian Li,[...]. J Neurooncol 2015
39
22

miR-622 inhibits angiogenesis by suppressing the CXCR4-VEGFA axis in colorectal cancer.
Yantian Fang, Bo Sun, Jiangli Wang, Yanong Wang. Gene 2019
22
22


Strong reduction of AGO2 expression in melanoma and cellular consequences.
D Völler, J Reinders, G Meister, A-K Bosserhoff. Br J Cancer 2013
34
22

Proteomics. Tissue-based map of the human proteome.
Mathias Uhlén, Linn Fagerberg, Björn M Hallström, Cecilia Lindskog, Per Oksvold, Adil Mardinoglu, Åsa Sivertsson, Caroline Kampf, Evelina Sjöstedt, Anna Asplund,[...]. Science 2015
22

Bioinformatic Identification of miR-622 Key Target Genes and Experimental Validation of the miR-622-RNF8 Axis in Breast Cancer.
Chuanyang Liu, Lu Min, Jingyu Kuang, Chushu Zhu, Xin-Yuan Qiu, Lingyun Zhu. Front Oncol 2019
9
22

Isolation of human hepatocytes by a two-step collagenase perfusion procedure.
Serene M L Lee, Celine Schelcher, Maresa Demmel, Maria Hauner, Wolfgang E Thasler. J Vis Exp 2013
61
22

microRNA-622 acts as a tumor suppressor in hepatocellular carcinoma.
Wei-Hua Song, Xiao-Jun Feng, Shao-Juan Gong, Jian-Ming Chen, Shou-Mei Wang, Dong-Juan Xing, Ming-Hua Zhu, Shu-Hui Zhang, Ai-Min Xu. Cancer Biol Ther 2015
30
22

Overexpression of YAP and TAZ is an independent predictor of prognosis in colorectal cancer and related to the proliferation and metastasis of colon cancer cells.
Lijuan Wang, Shengjia Shi, Zhangyan Guo, Xiang Zhang, Suxia Han, Angang Yang, Weihong Wen, Qing Zhu. PLoS One 2013
189
22


Neuroblastoma RAS Viral Oncogene Homolog (NRAS) Is a Novel Prognostic Marker and Contributes to Sorafenib Resistance in Hepatocellular Carcinoma.
Peter Dietrich, Anne Gaza, Laura Wormser, Valerie Fritz, Claus Hellerbrand, Anja Katrin Bosserhoff. Neoplasia 2019
16
22

Concomitant overexpression of the EGFR and erbB-2 genes in renal cell carcinoma (RCC) is correlated with dedifferentiation and metastasis.
G Stumm, S Eberwein, S Rostock-Wolf, H Stein, S Pomer, J Schlegel, R Waldherr. Int J Cancer 1996
79
22

Predictive Relevance of Circulating miR-622 in Patients with Newly Diagnosed and Recurrent High-Grade Serous Ovarian Carcinoma.
Nicolas Vigneron, Mégane Vernon, Matthieu Meryet-Figuière, Bernard Lambert, Mélanie Briand, Marie-Hélène Louis, Sophie Krieger, Florence Joly, Stéphanie Lheureux, Cécile Blanc-Fournier,[...]. Clin Chem 2020
11
22


Molecular bases of the poor response of liver cancer to chemotherapy.
Jose J G Marin, Oscar Briz, Elisa Herraez, Elisa Lozano, Maitane Asensio, Silvia Di Giacomo, Marta R Romero, Luis M Osorio-Padilla, Ana I Santos-Llamas, Maria A Serrano,[...]. Clin Res Hepatol Gastroenterol 2018
34
22

The Interaction Between Long Non-coding RNA HULC and MicroRNA-622 via Transfer by Extracellular Vesicles Regulates Cell Invasion and Migration in Human Pancreatic Cancer.
Kenji Takahashi, Kazuya Koyama, Yu Ota, Hidetaka Iwamoto, Keisuke Yamakita, Satoshi Fujii, Yohei Kitano. Front Oncol 2020
10
22

miRNAMap 2.0: genomic maps of microRNAs in metazoan genomes.
Sheng-Da Hsu, Chia-Huei Chu, Ann-Ping Tsou, Shu-Jen Chen, Hua-Chien Chen, Paul Wei-Che Hsu, Yung-Hao Wong, Yi-Hsuan Chen, Gian-Hung Chen, Hsien-Da Huang. Nucleic Acids Res 2008
200
22

miR-622 is a novel potential biomarker of breast carcinoma and impairs motility of breast cancer cells through targeting NUAK1 kinase.
Francesca Maria Orlandella, Raffaela Mariarosaria Mariniello, Peppino Mirabelli, Anna Elisa De Stefano, Paola Lucia Chiara Iervolino, Vito Alessandro Lasorsa, Mario Capasso, Rosa Giannatiempo, Maria Rongo, Mariarosaria Incoronato,[...]. Br J Cancer 2020
6
33

Molecular targeted and immune checkpoint therapy for advanced hepatocellular carcinoma.
Ziyu Liu, Yan Lin, Jinyan Zhang, Yumei Zhang, Yongqiang Li, Zhihui Liu, Qian Li, Ming Luo, Rong Liang, Jiazhou Ye. J Exp Clin Cancer Res 2019
61
22

MiR-622 functions as a tumor suppressor and directly targets E2F1 in human esophageal squamous cell carcinoma.
Changshan Song, Pingfang Lu, Weicheng Shi, Guoqiang Sun, Guangsuo Wang, Xujie Huang, Zheng Wang, Zhigang Wang. Biomed Pharmacother 2016
19
22


Hepatocellular carcinoma.
Josep M Llovet, Jessica Zucman-Rossi, Eli Pikarsky, Bruno Sangro, Myron Schwartz, Morris Sherman, Gregory Gores. Nat Rev Dis Primers 2016
22


GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses.
Zefang Tang, Chenwei Li, Boxi Kang, Ge Gao, Cheng Li, Zemin Zhang. Nucleic Acids Res 2017
22

MicroRNA-622 is a novel mediator of tumorigenicity in melanoma by targeting Kirsten rat sarcoma.
Peter Dietrich, Silke Kuphal, Thilo Spruss, Claus Hellerbrand, Anja K Bosserhoff. Pigment Cell Melanoma Res 2018
16
22

A human protein atlas for normal and cancer tissues based on antibody proteomics.
Mathias Uhlén, Erik Björling, Charlotta Agaton, Cristina Al-Khalili Szigyarto, Bahram Amini, Elisabet Andersen, Ann-Catrin Andersson, Pia Angelidou, Anna Asplund, Caroline Asplund,[...]. Mol Cell Proteomics 2005
911
22


miRTarBase 2020: updates to the experimentally validated microRNA-target interaction database.
Hsi-Yuan Huang, Yang-Chi-Dung Lin, Jing Li, Kai-Yao Huang, Sirjana Shrestha, Hsiao-Chin Hong, Yun Tang, Yi-Gang Chen, Chen-Nan Jin, Yuan Yu,[...]. Nucleic Acids Res 2020
245
22

EZH2-mediated loss of miR-622 determines CXCR4 activation in hepatocellular carcinoma.
Haiou Liu, Yidong Liu, Weisi Liu, Weijuan Zhang, Jiejie Xu. Nat Commun 2015
74
22

MicroRNAs Modulate Drug Resistance-Related Mechanisms in Hepatocellular Carcinoma.
Yuehui Liang, Qi Liang, Liang Qiao, Fang Xiao. Front Oncol 2020
13
22

Prognostic significance of the co-overexpression of fibroblast growth factor receptors 1, 2 and 4 in gastric cancer.
Hideaki Murase, Mikito Inokuchi, Yoko Takagi, Keiji Kato, Kazuyuki Kojima, Kenichi Sugihara. Mol Clin Oncol 2014
40
22

Downregulation of P-cadherin expression in hepatocellular carcinoma induces tumorigenicity.
Richard Bauer, Daniela Valletta, Karin Bauer, Wolfgang E Thasler, Arndt Hartmann, Martina Müller, Torsten E Reichert, Claus Hellerbrand. Int J Clin Exp Pathol 2014
21
22

Wild type Kirsten rat sarcoma is a novel microRNA-622-regulated therapeutic target for hepatocellular carcinoma and contributes to sorafenib resistance.
Peter Dietrich, Andreas Koch, Valerie Fritz, Arndt Hartmann, Anja Katrin Bosserhoff, Claus Hellerbrand. Gut 2018
48
22

Co-overexpression of HER2/HER3 is a predictor of impaired survival in breast cancer patients.
Anna S Berghoff, Rupert Bartsch, Matthias Preusser, Gerda Ricken, Guenther G Steger, Zsuzsanna Bago-Horvath, Margareta Rudas, Berthold Streubel, Peter Dubsky, Michael Gnant,[...]. Breast 2014
36
22

Tg(Grm1) transgenic mice: a murine model that mimics spontaneous uveal melanoma in humans?
Susanne Schiffner, Barbara M Braunger, Miriam M de Jel, Sarah E Coupland, Ernst R Tamm, Anja K Bosserhoff. Exp Eye Res 2014
24
22

An atlas of the protein-coding genes in the human, pig, and mouse brain.
Evelina Sjöstedt, Wen Zhong, Linn Fagerberg, Max Karlsson, Nicholas Mitsios, Csaba Adori, Per Oksvold, Fredrik Edfors, Agnieszka Limiszewska, Feria Hikmet,[...]. Science 2020
68
22

Molecular crosstalk between Y5 receptor and neuropeptide Y drives liver cancer.
Peter Dietrich, Laura Wormser, Valerie Fritz, Tatjana Seitz, Monica De Maria, Alexandra Schambony, Andreas E Kremer, Claudia Günther, Timo Itzel, Wolfgang E Thasler,[...]. J Clin Invest 2020
8
25

Melanoblasts in culture as an in vitro system to determine molecular changes in melanoma.
Anja Katrin Bosserhoff, Lisa Ellmann, Silke Kuphal. Exp Dermatol 2011
22
22


lncRNA MALAT1 modulates oxaliplatin resistance of gastric cancer via sponging miR-22-3p.
Zhenming Zhang, Ming Li, Zhitao Zhang. Onco Targets Ther 2020
24
11




Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.